← Leaderboards
Janet L Stanford
Fred Hutchinson Cancer Research Center
$12,426,000
Attributed
$12,426,000
Total exposure
17
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$12,426,000 · 17
By mechanism
R01$7,822,463 · 4
P50$3,380,570 · 7
R03$778,172 · 5
K05$444,795 · 1
Top collaborators
No co-investigators on record.
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Leland H Hartwell$53,865,504
- Polly A Newcomb$32,889,977
- Mark A Jenkins$6,613,341
- Gavin Ha$4,673,787
- Beth A Mueller$2,988,640
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstateCancer RiskClinical ResearchGenotypeGrantMaleMalignant NeoplasmsGenesCessation Of LifeMolecularTumorResourcesGuidelinesMutationInterestProstateBiologyHuman SubjectMorbidity - Disease RateDiagnosisCancer EtiologyMemberNeoplasm /Cancer EpidemiologyLink
Grant awards (51)
Project 1: Molecular Predictors of Prostate Cancer Progression and Mortality$358,069
P50 · FY2022 · CA · contact PI
Career Enhancement Program$67,943
P50 · FY2022 · CA · contact PI
Project 1: Molecular Predictors of Prostate Cancer Progression and Mortality$188,956
P50 · FY2021 · CA · contact PI
Project 1: Molecular Predictors of Prostate Cancer Progression and Mortality$181,897
P50 · FY2021 · CA · contact PI
Career Enhancement Program$44,537
P50 · FY2021 · CA · contact PI
Career Enhancement Program$39,099
P50 · FY2021 · CA · contact PI
Project 1: Molecular Predictors of Prostate Cancer Progression and Mortality$373,819
P50 · FY2019 · CA · contact PI
Career Enhancement Program$81,839
P50 · FY2019 · CA · contact PI
Project 1: Molecular Predictors of Prostate Cancer Progression and Mortality$432,473
P50 · FY2018 · CA · contact PI
Aggressive Prostate Cancer: Linking Epigenomics and Genetics for Prevention$88,959
K05 · FY2018 · CA · contact PI
Career Enhancement Program$87,321
P50 · FY2018 · CA · contact PI
Career Development Program$213,767
P50 · FY2017 · CA · contact PI
Aggressive Prostate Cancer: Linking Epigenomics and Genetics for Prevention$88,959
K05 · FY2017 · CA · contact PI
Career Development Program$212,144
P50 · FY2016 · CA · contact PI
Aggressive Prostate Cancer: Linking Epigenomics and Genetics for Prevention$88,959
K05 · FY2016 · CA · contact PI
Molecular Predictors of Prostate Cancer Progression and Mortality$217,045
P50 · FY2015 · CA · contact PI
Career Development Program$164,472
P50 · FY2015 · CA · contact PI
Aggressive Prostate Cancer: Linking Epigenomics and Genetics for Prevention$88,959
K05 · FY2015 · CA · contact PI
Molecular Predictors of Prostate Cancer Progression and Mortality$197,023
P50 · FY2014 · CA · contact PI
Career Development Program$165,573
P50 · FY2014 · CA · contact PI
Aggressive Prostate Cancer: Linking Epigenomics and Genetics for Prevention$88,959
K05 · FY2014 · CA · contact PI
Molecular Predictors of Prostate Cancer Progression and Mortality$203,220
P50 · FY2013 · CA · contact PI
Career Development Program$151,373
P50 · FY2013 · CA · contact PI
Plasma Vitamin D Levels and Prostate Cancer Outcomes$85,360
R03 · FY2011 · CA · contact PI
Plasma Vitamin D Levels and Prostate Cancer Outcomes$88,000
R03 · FY2010 · CA · contact PI
Estrogen Pathway Genes and Association with Prostate Cancer Risk$88,000
R03 · FY2009 · CA · contact PI
Genetic Epidemiology of Prostate Cancer$423,798
R01 · FY2008 · CA · contact PI
Estrogen Pathway Genes and Association with Prostate Cancer Risk$88,000
R03 · FY2008 · CA · contact PI
Inflammatory Pathway Gene Polymorphisms and Risk of Prostate Cancer$88,000
R03 · FY2008 · CA · contact PI
A genomic scan of hereditary prostate cancer families with an occurrence of colon$88,000
R03 · FY2008 · CA · contact PI
Genetic Epidemiology of Prostate Cancer$486,482
R01 · FY2007 · CA · contact PI
Inflammatory Pathway Gene Polymorphisms and Risk of Prostate Cancer$88,000
R03 · FY2007 · CA · contact PI
Genetic Epidemiology of Prostate Cancer$498,671
R01 · FY2006 · CA · contact PI
NSAIDS and Other Medications in Prostate Cancer Etiology$652,909
R01 · FY2005 · CA
Genetic Epidemiology of Prostate Cancer$450,000
R01 · FY2005 · CA
NSAIDS and Other Medications in Prostate Cancer Etiology$718,429
R01 · FY2004 · CA
Genetic Epidemiology of Prostate Cancer$475,868
R01 · FY2004 · CA
NSAIDS and Other Medications in Prostate Cancer Etiology$700,737
R01 · FY2003 · CA
GENETIC EPIDEMIOLOGY OF PROSTATE CANCER$435,916
R01 · FY2003 · CA
NSAIDS and Other Medications in Prostate Cancer Etiology$677,728
R01 · FY2002 · CA
GENETIC EPIDEMIOLOGY OF PROSTATE CANCER$423,218
R01 · FY2002 · CA
Oncogenic Human Papillomaviruses &Prostate Cancer Risk$78,312
R03 · FY2002 · CA
MOLECULAR PREDICTORS OF PROSTATE CANCER PROGRESSION AND MORTALITY$0
P50 · FY2002 · CA
NSAIDS and Other Medications in Prostate Cancer Etiology$494,270
R01 · FY2001 · CA
GENETIC EPIDEMIOLOGY OF PROSTATE CANCER$331,030
R01 · FY2001 · CA
GENETIC POLYMORPHISMS IN THE GSTPI LOCUS AND PROSTATE CA$213,370
R01 · FY2001 · ES
GENETIC POLYMORPHISMS AND PROSTATE CANCER RISK$102,321
R01 · FY2001 · CA
Oncogenic Human Papillomaviruses &Prostate Cancer Risk$86,500
R03 · FY2001 · CA
GENETIC EPIDEMIOLOGY OF PROSTATE CANCER$321,390
R01 · FY2000 · CA
GENETIC POLYMORPHISMS AND PROSTATE CANCER RISK$247,497
R01 · FY2000 · CA
GENETIC POLYMORPHISMS IN THE GSTPI LOCUS AND PROSTATE CA$168,829
R01 · FY2000 · ES